Bei Akademie registrieren
Regeneron, US75886F1075

Regeneron stock pre-market at EUR 719.65 ahead of the Xetra open

Published on 10/21/2026 at 08:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The biopharmaceutical company develops medicines through research and development. At Lang & Schwarz the stock trades pre-market at EUR 719.65 on October 21, 2026.

Business model and morning price

  • Regeneron develops medicines through research and development.
  • The market context for October 21, 2026 is covered by the latest market reports.
  • Regeneron stock trades pre-market at EUR 719.65 at 8:33 a.m. CEST at Lang & Schwarz on October 21, 2026.
Isometrische 3D-Illustration einer Bioreaktor- und Zellkultur-Prozesskette in Pastellfarben
Regeneron Pharma US75886F1075 stellt ein isometrisches 3D-Diagramm der Bioreaktor-Wertschöpfungskette samt Zellkultur und Aufreinigung dar, Illustration mit AI erstellt.

Regeneron develops medicines through research and development. The stock trades pre-market at EUR 719.65 at 8:33 a.m. CEST at Lang & Schwarz on October 21, 2026.

Ahead of the Xetra open

The pre-market price is EUR 719.65 at Lang & Schwarz. The bid is EUR 716.10 and the ask is EUR 723.20. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Regeneron stock.

Regeneron and the market

Regeneron earns money by developing medicines through research and development, including biologic and genetic medicines, for serious diseases, according to the company’s website. Market context: Latest market reports.

More news and analysis on Regeneron stock

Disclaimer...
en | US75886F1075 | REGENERON | boerse | 70380170 | bgmi